Abstract
Objective
Abnormally low flow conditions, sensed by the arterial endothelium, promote aneurysm rupture. Fibronectin (FN) is among the most abundant extracellular matrix proteins and is strongly upregulated in human aneurysms, suggesting a possible role in disease progression. Altered FN splicing can result in the inclusion of EIIIA and EIIIB exons, generally not expressed in adult tissues. We sought to explore the regulation of FN and its splicing and their possible roles in the vascular response to disturbed flow.
Approach and Results
We induced low and reversing flow in mice by partial carotid ligation, and assayed FN splicing in an endothelium-enriched intimal preparation. Inclusion of EIIIA and EIIIB was increased as early as 48hrs, with negligible increases in total FN expression. To test the function of EIIIA and EIIIB inclusion, we induced disturbed flow in EIIIAB-/- mice unable to include these exons and found that they developed focal lesions with hemorrhage and hypertrophy of the vessel wall. Acute deletion of floxed FN caused similar defects in response to disturbed flow, consistent with a requirement for the upregulation of the spliced isoforms, rather than a developmental defect. Recruited macrophages promote FN splicing, since their depletion by clodronate liposomes blocked the increase in endothelial EIIIA and EIIIB inclusion in the carotid model.
Conclusions
These results uncover a protective mechanism in the inflamed intima that develops under disturbed flow, by showing that splicing of FN mRNA in the endothelium, induced by macrophages, inhibits hemorrhage of the vessel wall.
Keywords: Fibronectin, Hemorrhage, Shear Stress, Macrophage, Alternative Splicing
Introduction
Risk of aneurysm is determined globally by genetic defects and locally by hemodynamic effects. Genetic risk is often traced to defects in extracellular matrix proteins, such as fibrillin1, collagens, fibulin-4 and elastin in the case of thoracic aneurysm 1, and collagens in intracranial aneurysm and hemorrhagic stroke 2, 3. Other pathways, such as TGFβ and lysyl oxidase, are indirectly linked to extracellular matrix (ECM) protein deposition or organization. However, even given pre-existing genetic defects, not all blood vessels develop aneurysms; hemodynamics are a critical determinant of the location of aneurysms. For example intracranial aneurysms are more likely to grow and rupture in regions of the vasculature with disturbed flow 4-6. The frictional force of flow, or shear stress, is sensed by the endothelium, which plays a critical role in regulating the vessels' response to these flows 7. Thus, ECM composition and the endothelial response to disturbed flow are key determinants of aneurysm progression.
Fibronectin (FN) is a principal component of the vascular ECM and is highly upregulated in human aneurysm 8, 9. The assembly of FN is considered a crucial step towards the assembly of new vascular ECM, and essential for the matrix integration of many of the aforementioned aneurysm-linked proteins 10. FN production and deposition by the endothelium is increased in vitro by low and disturbed flow, and increased FN has been observed in areas of vasculature chronically exposed to disturbed flow 11, 12. While its structural function might suggest protection, it could also promote pro-inflammatory signaling thought to drive aneurysm progression. FN deposition potently increases the pro-inflammatory signaling of overlying endothelial cells 13 and plays a prominent role in leukocyte recruitment in vivo 14. Thus, while the role of FN in aneurysm is not yet clear, it is poised to be a major player in regulating disease progression.
FN is alternatively spliced, resulting in variable inclusion of the EIIIA(EDA) and EIIIB(EDB) domains and portions of the variable (V or IIICS) domain 15, 16. Among vertebrates, EIIIA and EIIIB domains are as highly conserved at the amino acid level as other FN domains, suggesting strong evolutionary pressure 17. Their expression patterns are conserved among all vertebrates examined, including human, mouse, rat, cow, chicken, frog and zebrafish, most prominently around the developing heart and blood vessels. Nearly complete inclusion during early development drops to <5-10% post-natally. Although adults express very little EIIIA or EIIIB, inclusion is increased in a variety of vascular injuries resulting in damage to the endothelium, such as balloon or wire injury in animal models 18-21. Increased inclusion of EIIIA and EIIIB has also been observed in human aneurysms 22. But how expression of EIIIA and EIIIB is regulated in aneurysm progression remains unclear. Also unclear is how the production of EIIIA+EIIIB+ FN affects vasculature damaged by exposure to low and disturbed flow.
We hypothesized that low and disturbed flow might promote the increased inclusion of alternative exons EIIIA and EIIIB in the arterial endothelium and, furthermore, that the upregulation of these alternative exons might play a role in preventing the destructive effects of low and disturbed flow on the arterial endothelium. Here we describe experiments supporting these hypotheses.
Results
Low and disturbed arterial flow promotes increased inclusion of FN alternative exons, EIIIA and EIIIB
To examine alternative splicing in response to low and disturbed arterial flow, we performed near complete carotid ligation on C57BL/6J mice. This severely reduces mean blood velocity in the ligated carotid artery (by ∼75%, Figure 1 & 4) and results in the pro-inflammatory activation of the endothelium 23. We collected RNA from the intima of these mice by a Trizol flush following published methods, yielding a 3000-fold enrichment of endothelial mRNA Pecam1 (CD31) relative to smooth muscle mRNA acta2 (alpha-smooth muscle actin) in the intimal preparation relative to the remainder of the carotid artery (Figure IA online) 23, 24. Purified intimal RNA was pooled from three groups of 4-5 vessels for each flow regime: low-flow (ligated) or high-flow (contralateral to the ligated artery). The mRNA pool was sequenced and splicing assessed by MISO 25. We found that, at 48hrs, the levels of both EIIIA and EIIIB inclusion in the intima increased by about 3- to 4-fold over the levels in contralateral carotid intima (Figure 1A&B). Baseline levels of EIIIA inclusion (17%) were higher than EIIIB inclusion (5%), as were the levels under disturbed flow (55% for EIIIA and 19% for EIIIB).
Figure 1. Low and disturbed flow promotes inclusion of alternative exons EIIIA and EIIIB.
A) Relative read densities in EIIIA, EIIIB and flanking exons from the sequenced intimal RNA of low-flow (ligated) and high-flow (contralateral) carotid arteries 48hrs after surgery. Numbered curves indicate exon-spanning reads. B) Inclusive and exclusive reads were used by MISO to calculate the % inclusion rate (Psi) of alternative FN exons EIIIA and EIIIB. Average of three pools (4-5 arteries each) and the standard deviation is shown. (C&D) Exon inclusion in individual carotid arteries as measured by quantitative PCR at 48hrs (C) and 7 days (D) after nearly complete carotid ligation or sham operation. (E&F) Fold-change in FN over sham-operated contralateral artery. Each dot (C-F) represents analysis of the intimal flush from a single carotid artery. Significance of the difference between (B) low flow and high flow pools by Student's t test and (C-F) the ligated left carotid measurements and the other groups by ANOVA and Tukey's multiple comparison test : **P<0.01, ***P<0.001, ****P<0.0001.
Figure 4. Acute deletion of FN results in hemorrhage of the vessel wall.
A) Excised vessels and sections of carotid artery from the indicated genotypes, showing expression of the mT/mG reporter (left panel) which switches from red to green upon Cre excision. FN immunofluorescence staining of the same vessels is shown in the right panel. The ligations have been left on some vessels, to show their location distal to the site of the hemorrhages. Arrowheads point to hemorrhage. B) Hematoxylin and eosin stained sections from the carotid arteries shown above. Arrows point to blood beneath the endothelium (ROSA26-CreERT2; FNf/f) and between elastin layers of the media (Cdh5-CreERT2; SM22-Cre; FNf/f). Bottom right panel is immunofluorescence for CD31 (green), Ter-119 (red) and DAPI (blue). C) Mean ultrasound velocity from in vivo measurements at 7 days after nearly complete carotid ligation. Each dot is the measurement of a single carotid artery. Red dots indicate arteries with sub-endothelial hemorrhage, frequency of hemorrhage is indicated above. Scale bars = 100μm
RNA-seq analysis provided an aggregate assessment of splicing changes in a large pool of mice. To determine splicing changes with greater resolution in the intima of individual carotid arteries, we established a quantitative PCR (qPCR) assay to measure fold changes in the levels of EIIIA+ and EIIIB+ mRNAs relative to total FN mRNA (Figure II online). We extrapolated the actual inclusion rates from the qPCR data, using cDNA prepared from sequenced samples to calibrate.
Using these methods, we examined splicing in two more cohorts of mice, at 48hrs and at 7 days after nearly complete carotid ligation. We found that the mean changes in inclusion observed by qPCR in these new cohorts replicated the results obtained by RNA-seq. Under low-flow conditions, EIIIA and EIIIB inclusion rates increased 2- to 3-fold (from 19% to 47% for EIIIA and from 5% to 11% for EIIIB) over the high-flow contralateral carotid at 48hrs (Figure 1C). The high inclusion levels were maintained at the 7-day time-point (Figure 1D). We included sham-operated mice to control for splicing changes induced by the trauma of the surgery in the absence of flow changes. Although surgery alone induced a slight increase in EIIIA and EIIIB inclusion at 48hrs, this was less than the change induced by low and disturbed flow [compare Ligated Low(L) vs. Sham noΔ(L) at 48hrs], and the effect disappeared by 7 days. Interestingly, the change in splicing occurred without a significant change in the total FN expression at either 48hrs or 7 days (Figure 1E&F). Thus, low and disturbed flow acutely increases intimal EIIIA and EIIIB inclusion, as measured by two independent techniques, and this occurs without significant increases in total FN expression.
We then asked whether similar changes occurred in the media and adventitia, or whether they were confined to the intima. We used the same qPCR approach, except that analysis was performed on the remainder of the carotid artery, after the intimal flush. We found that, in contrast to the intimal changes, there were no significant differences in splicing between ligated and sham-operated arteries at 48hrs (Figure IIIA online). After exposure to 7 days of low and disturbed flow, inclusion of both EIIIA and EIIIB were increased around 2-fold in the media & adventitia relative to the sham-operated carotid (Figure IIIC online). So, EIIIA and EIIIB inclusion is also increased in the carotid media & adventitia by low and disturbed flow, but the magnitude of the switch is significantly lower than in the intima. There were no differences in total FN expression (Figure IIIB&D online).
Although enriched for endothelium, the intimal flush includes RNA from adherent leukocytes, as well as fibroblasts and smooth muscle cells. To confirm that the alternatively spliced FN transcripts in the intima were endothelium-derived, we used Cdh5-CreERT2 to excise floxed FN in the endothelium prior to disturbing flow (Figure IB online). Total FN expression was reduced ∼90% in the intima at 7 days, without a significant reduction in the media & adventitia. Similarly, there was a ∼90% reduction in EIIIA and EIIIB (Figure IC online). These results indicate that the endothelium is the primary source of alternatively spliced FN in the intimal response to altered shear.
Absence of EIIIA and EIIIB inclusion promotes hemorrhage of the vessel wall in response to low and disturbed flow
To test the function of EIIIA and EIIIB inclusion in the vascular response to low flow, we performed carotid ligation in EIIIA-/-; EIIIB-/- (EIIIAB-/-) mice unable to include EIIIA and EIIIB 26. After 7 days of low flow, carotid arteries of EIIIAB-/- mice showed localized hemorrhage of the vessel wall, typically associated with bulges in the artery (Figure 2A). To quantify these differences further, excised vessels were scored for an “injury” phenotype based on the degree of hemorrhage and/or bulging of the wall (Figure IV online). To confirm the presence of blood beneath the intimal endothelial cell layer, we performed immunofluorescence staining for the endothelial cell marker Pecam1 (CD31) and the erythrocyte marker Ter119. We found large areas of Ter119-labeled blood cells beneath the CD31-labeled endothelium, confirming that blood had leaked into the vessel wall and beneath the endothelium (Figure 2B and Figure V online). Although hemorrhages also occurred in the wild-type littermate controls, they were much less frequent (14% vs. 47%, P=0.02, Fisher's exact test). Importantly, we observed no differences in the level of flow reduction induced by carotid ligation in EIIIAB-/- and EIIIAB+/+ mice, indicating that the inability to alternatively splice FN is the underlying cause of the hemorrhages, rather than a quantitative difference in the hemodynamic stimulus (Figure 2C).
Figure 2. Mice deficient in EIIIA and EIIIB are prone to sub-endothelial hemorrhage in response to low and disturbed flow.
A) Isolated carotid arteries from EIIIAB-/- and EIIIAB+/+ mice after 7 days of low and disturbed flow conditions. Note the visible extravascular blood in the EIIIAB-/- mouse following saline perfusion (arrowheads). B) Combined staining for CD31 and Ter119 shows blood cells beneath the endothelium. Percent of mice with extravascular blood, following saline perfusion is shown in the graph. P=0.04 by two-tailed Fisher's exact test. C) Mean ultrasound velocity from in vivo measurements at 7 days after nearly complete carotid ligation. Each dot is the measurement of a single carotid artery. Red dots indicate arteries with sub-endothelial hemorrhage. Scale bars = 100μm and 25μm (higher magnification).
Histological analysis of the arteries suggests that a local expansion of the adventitia may contribute to the appearance of the bulged regions, since significant differences could be observed in thickness of the adventitia across multiple regions of EIIIAB-/- arteries versus EIIIAB+/+ or EIIIAB+/- arteries (Figure VI online). In addition to the localized expansion of the adventitia, we also observed focal dilation of the artery lumen in vivo, by high-resolution ultrasound images collected at the 7 day endpoint. These focal dilations resulted in regions 30-70% larger than adjacent sections of the same artery, and could be observed in 5/9 arteries with hemorrhage, and 2/9 arteries without obvious hemorrhage. Similar focal dilations did also occur in ligated EIIIAB+/+ control arteries, but the frequency was lower (8/26) overall, and followed a similar trend – appearing more often in arteries with hemorrhage (Figure VII online). Thus, hemorrhage was associated with both increased adventitial growth and lumen enlargement.
Based on proximity of the hemorrhage to the intimal layer, the severe damage to the VE-cadherin-labeled endothelial layer, and the ingrowth of VE-cadherin+ vessels from the intima into the vessel wall in vessels with bleeds (Supplementary Movie 1 and 2), we believe that these bleeds originate from the carotid lumen, rather than from the vasa vasorum. Hemorrhage and bulges were specific to the low-flow carotid artery, and never observed in sham-operated vessels (N=11) or contralateral arteries (N=110). Extravascular bleeding occurred at some point between 48hrs and 7 days, since it was never observed in any vessels harvested at 48hrs, including EIIIAB-/- (N=5) and a variety of other genotypes (N=101). Therefore, in mice unable to include alternative FN exons EIIIA and EIIIB, the intima is at increased risk of hemorrhage and injury when chronically exposed to low and disturbed flow. Notably, the most injured arteries had some of the highest inclusion levels recorded (Figure 1, colored points). Interestingly, this was specific to the intima, changes in medial splicing were not associated with the severity of the phenotype (Figure III online).
To determine whether the flow-induced hemorrhage could be linked to one of the two alternatively spliced domains, we examined EIIIA-/- mice unable to include EIIIA 20. These mice appeared to show a milder form of the vascular injury phenotype (Figure IV online) and instances of bleeding beneath the endothelium (Figure VIII online). Thus, the inability to include one of the two alternatively spliced exons may also increase the risk of hemorrhage, but with lower penetrance.
Since the hemorrhage and injury we observed resemble aspects of dissecting aneurysms, we tested whether the absence of EIIIA and EIIIB inclusion is increased in another model of aortic dissection, based on the systemic administration of a high-dose of angiotensin II (Ang-II) 27. In this model, Ang-II results in leukocyte recruitment, elastin degradation, medial apoptosis and partially penetrant dissection of the abdominal and thoracic aorta 28. Interestingly, despite abundant FN accumulation in the intima of Ang-II-treated mice, EIIIA and EIIIB inclusion was not increased to the same extent as in arteries exposed to low and disturbed flow, nor were mice deficient in EIIIA and EIIIB at increased risk of abdominal aorta dissection in this model (Figure IX online). Thus, alternative FN splicing is more regulated and essential to the vascular response to low and disturbed flow than to Ang-II driven aortic dissection.
Absence of EIIIA and EIIIB does not inhibit FN expression or deposition
The development of vessel wall hemorrhage in EIIIAB-/- mice led us to question whether the absence of EIIIA and EIIIB resulted in reduced FN expression or deposition. We examined constitutive FN mRNA in the intimal flush and in the remaining media & adventitia of EIIIAB-/- mice and littermate controls subjected to nearly complete carotid ligation. We found that there was no difference in the level of total FN mRNA in the intima at 7 days after nearly complete carotid ligation in EIIIAB-/- mice relative to their littermate controls (Figure 3A). So, the absence of EIIIA and EIIIB did not impinge on the levels of FN transcript in either the intima or the media & adventitia.
Figure 3. Deficiency in EIIIA and EIIIB does not inhibit FN expression or deposition.
A) Expression of FN mRNA in the intima and media/adventitia of EIIIAB+/+ and EIIIAB-/- mice 7 days after ligation or sham operation. Each dot represents analysis of the intimal flush from a single carotid artery. B) Immunofluorescence staining for total FN (red) and CD31 (green) in sections of carotid arteries, 7 days after ligation, with and without severe injury. C) Fluorescence intensity in sections of ligated carotid arteries in the intima or in the medial cell layers. Each dot represents a single carotid artery. **P<0.01 by two-tailed Student's t test. Scale bars = 100μm
At the protein level, results were similar. Increased FN deposition could be observed in the intima of ligated carotid arteries, relative to sham-operated controls, but the level of staining was not significantly reduced in EIIIAB-/- mice (Figure 3B). Instead, there was increased deposition of FN in the intima of EIIIAB-/- mice, as determined by quantitative immunofluorescence (Figure 3C). Although all mice that developed vessel wall hemorrhage had high levels of intimal FN, only in the EIIIAB-/- group was FN deposition increased in the absence of severe injury (score ≥2). It is not yet clear whether the increased FN deposition represents leak of plasma FN; extravasation of plasma albumin was not significantly increased by the same methods, although it was increased relative to the contralateral artery (Figure X online).
Acute deletion of FN promotes hemorrhage of the vessel wall in response to low and disturbed flow
Hemorrhage in response to low and disturbed flow could be a consequence of the absence of the EIIIA and EIIIB isoforms throughout vascular development, the inability to increase the expression of these isoforms under low and disturbed flow, or both. To tease apart these possibilities, we investigated whether there was an acute requirement for FN expression in the response to low and disturbed flow. We had previously observed that the acute deletion of floxed FN in the endothelium by Cdh5-CreERT2 almost entirely ablated endothelial FN mRNA (Figure I online), but did not predispose to flow-induced hemorrhage (Figure 4 and Figure IV online). However, our analysis of FN splicing had revealed increased EIIIA+EIIIB+ FN mRNA in the adjacent media following carotid ligation (Figure IIIC online), suggesting that smooth muscle cells may be compensating for endothelial FN production. Further supporting this line of reasoning, there was a trend towards increased expression of EIIIA+ and EIIIB+ FN in the media & adventitia of Cdh5-CreERT2; FNf/f mice subjected to nearly complete carotid ligation (Figure IC online).
To determine whether FN production by mural cells is able to compensate for the acute deletion of FN in the endothelium we took two complementary approaches, using Rosa26-CreERT2; FNf/f mice to delete FN acutely and globally <1 week before carotid ligation, and a combination of SM22-Cre and Cdh5-CreERT2 to acutely delete endothelial FN <1 week before carotid ligation in the absence of smooth muscle FN.
As expected, Rosa26-CreERT2 effectively activated a Cre reporter throughout most, but not all, of the endothelial and smooth muscle cells (Figure 4) and ablated plasma FN within 2 days (data not shown), resulting in a nearly complete inhibition of FN protein deposition in the intima of vessels exposed to low and disturbed flow (Figure 4). Without the ability to acutely increase FN production, arteries were susceptible to hemorrhage (2/8 mice and none of the littermate controls) and almost all of the arteries demonstrated a failure in inward remodeling (Figure 4, Figure IV and VII online). In fact, the lumen of many of the arteries enlarged beyond the size of sham-operated controls (Figure VII online). Importantly, neither injury nor hemorrhage were observed in the contralateral arteries or sham-operated Rosa26-CreERT2; FNf/f arteries, indicating that enlargement of the artery and hemorrhage were specifically induced by low and disturbed flow conditions, rather than by the acute ablation of FN expression.
However, Rosa26-CreERT2 removes all sources of FN production, including EIIIA-EIIIB- plasma FN. To address more specifically the acute requirement for the EIIIA+ and EIIIB+ FN variants produced by the endothelium, and to delete FN more stringently in the vessel wall, we examined Cdh5-CreERT2; SM22-Cre; FNf/f mice after the acute deletion of endothelial FN (<1 week prior to nearly complete carotid ligation). SM22-Cre allowed stronger deletion of FN in the vessel wall than Rosa26-CreERT2, and Cdh5-CreERT2 was more effective in the deletion of endothelial FN than Rosa26-CreERT2. Despite abundant FN in the intima, presumably plasma-derived and EIIIA-EIIIB-, arteries unable to produce EIIIA+ and EIIIB+ FN variants in the endothelium developed hemorrhage. Importantly, none of these defects was observed in SM22-Cre; FNf/f littermates, which were born in Mendelian ratios without noticeable vascular defects (Figure 4 and Figure IV online) and resembled littermate FNf/f mice in carotid structure and response to low and disturbed flow, indicating that the defects observed were a result of the absence of endothelial FN.
Therefore, both approaches that acutely blocked the ability to produce new endothelial EIIIA+EIIIB+ FN replicated the hemorrhages in the vessel wall observed in EIIIAB-/- mice. Notably, of the two approaches, a stronger phenotype was observed using Cdh5-CreERT2; SM22-Cre; FNf/f than Rosa26-CreERT2, despite the presence of abundant remaining plasma FN.
Macrophages are required for the induction of EIIIA and EIIIB in the vessel wall
Given the importance of the endothelial FN splicing switch in preventing the damaging effects of disturbed blood flow on the vessel wall, we investigated how the splicing switch is regulated. We found that macrophages, which are often recruited to sites of injury where EIIIA and EIIIB expression is increased, are recruited to the carotid arterial endothelium under disturbed flow conditions (Figure XI online). Therefore, we hypothesized that they might promote EIIIA and EIIIB inclusion.
To test this, we used clodronate liposomes to deplete macrophages in mice subjected to carotid ligation, and examined EIIIA and EIIIB expression in the intimal flush. Analysis of the macrophage-specific mRNA Cd68 revealed that the 7-fold increase induced by low and disturbed flow conditions could be completely blocked by clodronate-liposome treatment (Figure 5A). Inhibiting the recruitment of macrophages resulted in a suppression of increased FN expression (Figure 5B) and a complete abrogation of the induction of EIIIA and EIIIB by low and disturbed flow (Figure 5C&D). Therefore, the switch in endothelial splicing under low and disturbed flow depends on macrophages, which are recruited in large numbers under these conditions.
Figure 5. Endothelial EIIIA and EIIIB inclusion is increased in response to recruited macrophages.
A) Expression of CD68, a marker of macrophages, in the intimal RNA of C57BL/6J mice 48hrs after nearly complete carotid ligation, with or without prior treatment with chlodronate, as determined by quantitative PCR. B) Fold-change in FN expression, relative to the contralateral control from PBS liposome treated mice. C&D) Inclusion frequency of EIIIA (C) and EIIIB (D) in the intimal mRNA of the same C57BL/6J mice, as determined by quantitative PCR. (B-D). Each dot represents analysis of the intimal flush from a single carotid artery. ANOVA and Tukey's multiple comparison test **P<0.01, ***P<0.001.
Discussion
Low and disturbed arterial flow is known to promote aneurysm growth and rupture 5, 6. The ECM is profoundly altered in late-stage aneurysms, but how disturbed flow regulates ECM composition in vivo remains poorly characterized. Furthermore, how acute changes in individual ECM components during aneurysm formation might contribute to or inhibit further progression is unclear. Here, we show that macrophages, recruited by disturbed flow 29, promote a rapid change in FN splicing resulting in increased expression of EIIIA+ and EIIIB+ variants as early as 48hrs after a change in flow. The acute upregulation of these isoforms inhibits hemorrhage of the vessel wall, revealing a protective splicing mechanism in the vascular endothelium of regions exposed to severely disturbed flow.
Upregulation of alternative splice variants of FN protects against hemorrhage of the vessel wall under low and disturbed flow
Our results suggest that alternative FN splicing in the vessel wall is an important protective mechanism against hemorrhagic rupture of the intima, and therefore may play a role in the growth and rupture of areas of aneurysm exposed to disturbed flow. Increased EIIIA and EIIIB inclusion has been observed in late-stage human aortic aneurysms 22. Interestingly, EIIIA failed to increase in a subgroup of patients at higher risk of dissecting aneurysm 22. The same patient group (bicuspid aortic valve) is also at increased risk of intracranial aneurysm, although it is not clear whether this is due to altered FN splicing 30. Given the phenotypic complexity of human samples, these observations remained correlative. Here, we provide genetic evidence that deficient EIIIA and EIIIB inclusion directly increases the risk of damage to the vessel wall.
It is not clear why deficiency in EIIIA and EIIIB inclusion promotes hemorrhage in response to disturbed flow but not in response to Ang-II. Perhaps one clue lies in the cell types most affected. Low and disturbed flow acts primarily on the endothelium. In the carotid ligation model, macrophage accumulation and changes in FN splicing were strongest in the intima. In contrast, it has been proposed that macrophages recruited to the adventitia drive aortic dissection in the Ang-II model 31. Our data show that both macrophage recruitment and alternative FN splicing are reduced in the Ang-II intima, relative to the intima of vessels exposed to low and disturbed flow. Thus, we suggest that alternative FN splicing will be of greatest importance in preventing vascular damage in diseases with a strong component of endothelial activation and inflammation.
The mechanisms of protection conferred by EIIIA and EIIIB are of considerable interest. Several might be proposed: 1) EIIIA is known to bind and activate TLR4. This could skew macrophage phenotype directly, or affect the presentation of autoantigens from the lesion to innate immune cells (EIIIA has been shown to be a potent adjuvant, and immunization of mice with FN decreases atherosclerotic vascular injury) 32, 33; 2) EIIIA inclusion in full-length recombinant FN has been shown to increase cell spreading in vitro suggesting that it may affect proliferation and apoptosis pathways linked to spreading 34; 3) Suppressing EIIIA and EIIIB inclusion in endothelial cells may affect fibrillogenesis 35, and thus both endothelial cell-cell junctions and permeability 36; 4) Mice with increased EIIIA inclusion clot faster under arterial flow rates 37, suggesting that increasing EIIIA (and perhaps also EIIIB) inclusion may help quickly staunch intimal hemorrhage. A better understanding of how EIIIA and EIIIB prevent vessel damage should reveal new ways in which the vasculature locally resists flow-induced damage.
Macrophages promote the increased EIIIA and EIIIB inclusion in the endothelium
We show that macrophage recruitment is critical for the increased expression of EIIIA and EIIIB. In a variety of other fibrotic injury settings, such as organ transplant rejection, and skin, lung, kidney and liver damage and cancer, EIIIA and EIIIB inclusion is increased 16. Among isolated cell types from the liver, endothelial cells showed the strongest increase in inclusion 38. This switch is thought to be one of the earliest steps in fibrosis, which is EIIIA-dependent in both lung and liver injury models 39, 40. Our data suggest that recruitment or activation of macrophages could provide signals to promote EIIIA inclusion. The specific mechanisms through which they induce FN splicing are not yet clear, but we have observed a good correlation between PAI1 and the inclusion of EIIIA and EIIIB, as well as total FN expression (Figure XII online), perhaps implicating TGFβ - known to regulate PAI1 and EIIIA inclusion in vitro 41. Conditional deletion of macrophages has revealed a critical role in driving fibrosis in the liver and the lung 42, 43. So, in a variety of fibrotic settings, macrophages may play a similar role in the induction of alternative FN splicing, with important implications for the composition and signaling of the fibrotic ECM.
Increased numbers of macrophages are found in ruptured intracranial aneurysms, and clodronate depletion experiments suggest macrophages drive the growth of intracranial aneurysms in elastase-induced animal models 44, 45. We observed that the chronic depletion of macrophages in our carotid ligation model acutely suppresses the flow-mediated activation of the endothelium (indicated by reduced intimal PAI-1 and α-Smooth muscle actin expression, Figure XIII online) and arterial stiffness (indicated by pulse distension, Figure XIII online), markers of arterial injury. Our current model (summarized in Figure XIV online) is that the exposure of the arterial endothelium to reduced blood flow increases the expression of leukocyte adhesion receptors (e.g., ICAM and VCAM), resulting in the recruitment of blood-derived monocytes to the intima. Monocytes differentiate to macrophages and elicit changes in the endothelium, including the alternative splicing of FN, that are critical in preventing damage to the vessel wall. Since macrophages are also instigators of arterial injury, alternative FN splicing in the endothelium may be thought of as a mechanism induced by macrophages that protects against their own damaging effects on the vessel wall.
Acute flow-induced hemorrhage of the vessel wall
Hemorrhage in the carotid artery under disturbed flow came as a surprise, since other investigators used the same model, and even inhibited FN assembly (using a small peptide inhibitor) but did not report vessel-wall hemorrhage 46-48. A likely explanation is that the penetrance of this phenotype on the wild-type background is low (4/27 AB+/+ littermate controls, 0/15 C57 mice +/- clodronate liposomes, 1/9 EIIIA+/- littermate controls, 0/22 FNf/f or FNf/+ littermate controls), and may have escaped the notice of previous investigators. In a typical cohort of 5 to 10 mice, such defects would be rare. However, in the EIIIAB-/-, ROSA-CreER; FNf/f and Cdh5-CreER; SM22-Cre; FNf/f mice, hemorrhage within the vessel wall was seen in higher numbers (9/19, 2/8 and 2/8 respectively) and thus was obvious. It is also possible that hemorrhage occurs acutely and is resolved by later, 2-3 week time points; we have not yet examined this in detail. Consistent with the idea that vessel-wall hemorrhage is a partially penetrant phenotype that can be exacerbated by genetic background, hemorrhage has been observed in the carotid plaques of ApoE-deficient mice subjected to nearly complete carotid ligation 23, 49. Similar to these ApoE-/- hemorrhages, we noted endothelial sprouting into the vessel wall 50 (Supplementary Movie 1 & 2). Interestingly, our en face imaging suggests that these sprouts originate from the lumen, rather than the vasa vasorum. Therefore, we suggest that the established carotid ligation model can be used as a platform to investigate the contributions of various genetic and epigenetic regulators of disturbed flow on intimal damage and hemorrhage of the vessel wall.
In conclusion, we report that the alternatively spliced EIIIA and EIIIB exons of FN, long-known to be conserved and highly regulated in all vertebrates but without clearly understood functions, play a significant role in protecting the vasculature from inflammation caused by disturbed flow. They are upregulated in response to disturbed flow by recruited macrophages, and if this upregulation is prevented, hemorrhagic injury of the vessel wall ensues. Since inclusion of these two domains of FN occurs in many pathological situations (atherosclerosis, myocardial infarction, organ transplant and other fibroses, angiogenesis and tumor progression), further investigation of the regulation and function of FN splicing is warranted. An emerging view is that alternative-splicing programs broadly regulate tissue function 51, 52. FN is likely only one of many genes affected by splicing changes in the activated vascular endothelium. Future work should aim to dissect the regulation and function of these splicing programs.
Supplementary Material
Significance.
Aneurysms are fairly common in the brain, aorta and elsewhere, but their catastrophic rupture is not. Disturbed flow within brain aneurysms is one of the best predictors of rupture, risk of which is strongly modified by extracellular matrix composition. Fibronectin (FN), an essential extracellular matrix protein, is abundant in human aneurysms where it is also alternatively spliced. However, neither the regulation of alternative FN splicing nor its impact on the vasculature have been clear.
Here, we show that disturbed flow promotes alternative splicing of FN in the endothelium. Furthermore, we show that the splicing change is protective, since mutant mice unable to produce alternatively spliced FN are at increased risk of hemorrhage of the vessel wall. Mechanistically, we found that alternative FN splicing was almost entirely dependent on macrophages, recruited to the endothelium by disturbed flow. These results indicate that alternative FN splicing protects against the damaging effects of disturbed flow on the arterial wall.
Acknowledgments
We thank members of the Hynes lab for advice and discussions, especially Chris Turner and Tom Seegar. We thank the Swanson Biotechnology Center at the Koch Institute/MIT, especially the Applied Therapeutics & Whole Animal Imaging Facility, the Hope Babette Tang (1983) Histology Facility, the Microscopy Facility, the Barbara K. Ostrom (1978) Bioinformatics and Computing Facility, and Scott Malstrom, Denise Crowley, Eliza Vasile, Charlie Whittaker and Vincent Butty of the respective cores for exceptional technical support. The authors wish to dedicate this paper to the memory of Officer Sean Collier for his caring service to the MIT community.
Sources of funding: This work was supported by NIH grants to PAM (5F32HL110484) and to ROH (PO1-HL66105 (PI Monty Krieger) and by the Howard Hughes Medical Institute of which ROH is an Investigator) and was supported in part by the Koch Institute Support (core) Grant P30-CA14051 from the National Cancer Institute.
Abbreviation
- ECM
Extracellular Matrix
- EIIIA
Alternative exon EIIIA(EDA) of Fibronectin
- EIIIB
Alternative exon EIIIB(EDB) of Fibronectin
- EC
Endothelial cell
- Ang-II
Angiotensin-II
- qPCR
Quantitative PCR
Footnotes
Disclosures: None
References
- 1.Lindsay ME, Dietz HC. Lessons on the pathogenesis of aneurysm from heritable conditions. Nature. 2011;473:308–316. doi: 10.1038/nature10145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Gould DB, Phalan FC, Breedveld GJ, van Mil SE, Smith RS, Schimenti JC, Aguglia U, van der Knaap MS, Heutink P, John SW. Mutations in col4a1 cause perinatal cerebral hemorrhage and porencephaly. Science. 2005;308:1167–1171. doi: 10.1126/science.1109418. [DOI] [PubMed] [Google Scholar]
- 3.Plaisier E, Gribouval O, Alamowitch S, Mougenot B, Prost C, Verpont MC, Marro B, Desmettre T, Cohen SY, Roullet E, Dracon M, Fardeau M, Van Agtmael T, Kerjaschki D, Antignac C, Ronco P. Col4a1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. The New England journal of medicine. 2007;357:2687–2695. doi: 10.1056/NEJMoa071906. [DOI] [PubMed] [Google Scholar]
- 4.Sadasivan C, Fiorella DJ, Woo HH, Lieber BB. Physical factors effecting cerebral aneurysm pathophysiology. Annals of biomedical engineering. 2013;41:1347–1365. doi: 10.1007/s10439-013-0800-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Xiang J, Natarajan SK, Tremmel M, Ma D, Mocco J, Hopkins LN, Siddiqui AH, Levy EI, Meng H. Hemodynamic-morphologic discriminants for intracranial aneurysm rupture. Stroke; a journal of cerebral circulation. 2011;42:144–152. doi: 10.1161/STROKEAHA.110.592923. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Boussel L, Rayz V, McCulloch C, Martin A, Acevedo-Bolton G, Lawton M, Higashida R, Smith WS, Young WL, Saloner D. Aneurysm growth occurs at region of low wall shear stress: Patient-specific correlation of hemodynamics and growth in a longitudinal study. Stroke; a journal of cerebral circulation. 2008;39:2997–3002. doi: 10.1161/STROKEAHA.108.521617. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Conway DE, Schwartz MA. Flow-dependent cellular mechanotransduction in atherosclerosis. Journal of cell science. 2013;126:5101–5109. doi: 10.1242/jcs.138313. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Peters DG, Kassam AB, Feingold E, Heidrich-O'Hare E, Yonas H, Ferrell RE, Brufsky A. Molecular anatomy of an intracranial aneurysm: Coordinated expression of genes involved in wound healing and tissue remodeling. Stroke; a journal of cerebral circulation. 2001;32:1036–1042. doi: 10.1161/01.str.32.4.1036. [DOI] [PubMed] [Google Scholar]
- 9.Hynes RO. Cell-matrix adhesion in vascular development. Journal of thrombosis and haemostasis : JTH. 2007;5(Suppl 1):32–40. doi: 10.1111/j.1538-7836.2007.02569.x. [DOI] [PubMed] [Google Scholar]
- 10.Singh P, Carraher C, Schwarzbauer JE. Assembly of fibronectin extracellular matrix. Annual review of cell and developmental biology. 2010;26:397–419. doi: 10.1146/annurev-cellbio-100109-104020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Orr AW, Sanders JM, Bevard M, Coleman E, Sarembock IJ, Schwartz MA. The subendothelial extracellular matrix modulates nf-kappab activation by flow: A potential role in atherosclerosis. The Journal of cell biology. 2005;169:191–202. doi: 10.1083/jcb.200410073. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Feaver RE, Gelfand BD, Wang C, Schwartz MA, Blackman BR. Atheroprone hemodynamics regulate fibronectin deposition to create positive feedback that sustains endothelial inflammation. Circulation research. 2010;106:1703–1711. doi: 10.1161/CIRCRESAHA.109.216283. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Hahn C, Schwartz MA. The role of cellular adaptation to mechanical forces in atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology. 2008;28:2101–2107. doi: 10.1161/ATVBAHA.108.165951. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Rohwedder I, Montanez E, Beckmann K, Bengtsson E, Duner P, Nilsson J, Soehnlein O, Fassler R. Plasma fibronectin deficiency impedes atherosclerosis progression and fibrous cap formation. EMBO molecular medicine. 2012;4:564–576. doi: 10.1002/emmm.201200237. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Hynes RO. The extracellular matrix: Not just pretty fibrils. Science. 2009;326:1216–1219. doi: 10.1126/science.1176009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Astrof S, Hynes RO. Fibronectins in vascular morphogenesis. Angiogenesis. 2009;12:165–175. doi: 10.1007/s10456-009-9136-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Hynes RO. The evolution of metazoan extracellular matrix. The Journal of cell biology. 2012;196:671–679. doi: 10.1083/jcb.201109041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Dubin D, Peters JH, Brown LF, Logan B, Kent KC, Berse B, Berven S, Cercek B, Sharifi BG, Pratt RE, et al. Balloon catheterization induced arterial expression of embryonic fibronectins. Arteriosclerosis, thrombosis, and vascular biology. 1995;15:1958–1967. doi: 10.1161/01.atv.15.11.1958. [DOI] [PubMed] [Google Scholar]
- 19.Glukhova MA, Frid MG, Shekhonin BV, Vasilevskaya TD, Grunwald J, Saginati M, Koteliansky VE. Expression of extra domain a fibronectin sequence in vascular smooth muscle cells is phenotype dependent. The Journal of cell biology. 1989;109:357–366. doi: 10.1083/jcb.109.1.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Tan MH, Sun Z, Opitz SL, Schmidt TE, Peters JH, George EL. Deletion of the alternatively spliced fibronectin eiiia domain in mice reduces atherosclerosis. Blood. 2004;104:11–18. doi: 10.1182/blood-2003-09-3363. [DOI] [PubMed] [Google Scholar]
- 21.Fiechter M, Frey K, Fugmann T, Kaufmann PA, Neri D. Comparative in vivo analysis of the atherosclerotic plaque targeting properties of eight human monoclonal antibodies. Atherosclerosis. 2011;214:325–330. doi: 10.1016/j.atherosclerosis.2010.11.027. [DOI] [PubMed] [Google Scholar]
- 22.Paloschi V, Kurtovic S, Folkersen L, Gomez D, Wagsater D, Roy J, Petrini J, Eriksson MJ, Caidahl K, Hamsten A, Liska J, Michel JB, Franco-Cereceda A, Eriksson P. Impaired splicing of fibronectin is associated with thoracic aortic aneurysm formation in patients with bicuspid aortic valve. Arteriosclerosis, thrombosis, and vascular biology. 2011;31:691–697. doi: 10.1161/ATVBAHA.110.218461. [DOI] [PubMed] [Google Scholar]
- 23.Nam D, Ni CW, Rezvan A, Suo J, Budzyn K, Llanos A, Harrison D, Giddens D, Jo H. Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosis. American journal of physiology. Heart and circulatory physiology. 2009;297:H1535–1543. doi: 10.1152/ajpheart.00510.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Nam D, Ni CW, Rezvan A, Suo J, Budzyn K, Llanos A, Harrison DG, Giddens DP, Jo H. A model of disturbed flow-induced atherosclerosis in mouse carotid artery by partial ligation and a simple method of rna isolation from carotid endothelium. Journal of visualized experiments : JoVE. 2010 doi: 10.3791/1861. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Katz Y, Wang ET, Airoldi EM, Burge CB. Analysis and design of rna sequencing experiments for identifying isoform regulation. Nature methods. 2010;7:1009–1015. doi: 10.1038/nmeth.1528. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Astrof S, Crowley D, Hynes RO. Multiple cardiovascular defects caused by the absence of alternatively spliced segments of fibronectin. Dev Biol. 2007;311:11–24. doi: 10.1016/j.ydbio.2007.07.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Daugherty A, Manning MW, Cassis LA. Angiotensin ii promotes atherosclerotic lesions and aneurysms in apolipoprotein e-deficient mice. The Journal of clinical investigation. 2000;105:1605–1612. doi: 10.1172/JCI7818. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Daugherty A, Cassis LA. Mouse models of abdominal aortic aneurysms. Arteriosclerosis, thrombosis, and vascular biology. 2004;24:429–434. doi: 10.1161/01.ATV.0000118013.72016.ea. [DOI] [PubMed] [Google Scholar]
- 29.Walpola PL, Gotlieb AI, Langille BL. Monocyte adhesion and changes in endothelial cell number, morphology, and f-actin distribution elicited by low shear stress in vivo. The American journal of pathology. 1993;142:1392–1400. [PMC free article] [PubMed] [Google Scholar]
- 30.Schievink WI, Raissi SS, Maya MM, Velebir A. Screening for intracranial aneurysms in patients with bicuspid aortic valve. Neurology. 2010;74:1430–1433. doi: 10.1212/WNL.0b013e3181dc1acf. [DOI] [PubMed] [Google Scholar]
- 31.Tieu BC, Lee C, Sun H, Lejeune W, Recinos A, 3rd, Ju X, Spratt H, Guo DC, Milewicz D, Tilton RG, Brasier AR. An adventitial il-6/mcp1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. The Journal of clinical investigation. 2009;119:3637–3651. doi: 10.1172/JCI38308. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Arribillaga L, Durantez M, Lozano T, Rudilla F, Rehberger F, Casares N, Villanueva L, Martinez M, Gorraiz M, Borras-Cuesta F, Sarobe P, Prieto J, Lasarte JJ. A fusion protein between streptavidin and the endogenous tlr4 ligand eda targets biotinylated antigens to dendritic cells and induces t cell responses in vivo. BioMed research international. 2013;2013:864720. doi: 10.1155/2013/864720. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Duner P, To F, Beckmann K, Bjorkbacka H, Fredrikson GN, Nilsson J, Bengtsson E. Immunization of apoe-/- mice with aldehyde-modified fibronectin inhibits the development of atherosclerosis. Cardiovascular research. 2011;91:528–536. doi: 10.1093/cvr/cvr101. [DOI] [PubMed] [Google Scholar]
- 34.Manabe R, Oh-e N, Sekiguchi K. Alternatively spliced eda segment regulates fibronectin-dependent cell cycle progression and mitogenic signal transduction. The Journal of biological chemistry. 1999;274:5919–5924. doi: 10.1074/jbc.274.9.5919. [DOI] [PubMed] [Google Scholar]
- 35.Cseh B, Fernandez-Sauze S, Grall D, Schaub S, Doma E, Van Obberghen-Schilling E. Autocrine fibronectin directs matrix assembly and crosstalk between cell-matrix and cell-cell adhesion in vascular endothelial cells. Journal of cell science. 2010;123:3989–3999. doi: 10.1242/jcs.073346. [DOI] [PubMed] [Google Scholar]
- 36.Faurobert E, Rome C, Lisowska J, Manet-Dupe S, Boulday G, Malbouyres M, Balland M, Bouin AP, Keramidas M, Bouvard D, Coll JL, Ruggiero F, Tournier-Lasserve E, Albiges-Rizo C. Ccm1-icap-1 complex controls beta1 integrin-dependent endothelial contractility and fibronectin remodeling. The Journal of cell biology. 2013;202:545–561. doi: 10.1083/jcb.201303044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Chauhan AK, Kisucka J, Cozzi MR, Walsh MT, Moretti FA, Battiston M, Mazzucato M, De Marco L, Baralle FE, Wagner DD, Muro AF. Prothrombotic effects of fibronectin isoforms containing the eda domain. Arteriosclerosis, thrombosis, and vascular biology. 2008;28:296–301. doi: 10.1161/ATVBAHA.107.149146. [DOI] [PubMed] [Google Scholar]
- 38.Jarnagin WR, Rockey DC, Koteliansky VE, Wang SS, Bissell DM. Expression of variant fibronectins in wound healing: Cellular source and biological activity of the eiiia segment in rat hepatic fibrogenesis. The Journal of cell biology. 1994;127:2037–2048. doi: 10.1083/jcb.127.6.2037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Muro AF, Moretti FA, Moore BB, Yan M, Atrasz RG, Wilke CA, Flaherty KR, Martinez FJ, Tsui JL, Sheppard D, Baralle FE, Toews GB, White ES. An essential role for fibronectin extra type iii domain a in pulmonary fibrosis. American journal of respiratory and critical care medicine. 2008;177:638–645. doi: 10.1164/rccm.200708-1291OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Olsen AL, Sackey BK, Marcinkiewicz C, Boettiger D, Wells RG. Fibronectin extra domain-a promotes hepatic stellate cell motility but not differentiation into myofibroblasts. Gastroenterology. 2012;142:928–937 e923. doi: 10.1053/j.gastro.2011.12.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.George J, Roulot D, Koteliansky VE, Bissell DM. In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type ii receptor: A potential new therapy for hepatic fibrosis. Proceedings of the National Academy of Sciences of the United States of America. 1999;96:12719–12724. doi: 10.1073/pnas.96.22.12719. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, Vuthoori S, Wu S, Lang R, Iredale JP. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. The Journal of clinical investigation. 2005;115:56–65. doi: 10.1172/JCI22675. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Gibbons MA, MacKinnon AC, Ramachandran P, Dhaliwal K, Duffin R, Phythian-Adams AT, van Rooijen N, Haslett C, Howie SE, Simpson AJ, Hirani N, Gauldie J, Iredale JP, Sethi T, Forbes SJ. Ly6chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. American journal of respiratory and critical care medicine. 2011;184:569–581. doi: 10.1164/rccm.201010-1719OC. [DOI] [PubMed] [Google Scholar]
- 44.Frosen J, Piippo A, Paetau A, Kangasniemi M, Niemela M, Hernesniemi J, Jaaskelainen J. Remodeling of saccular cerebral artery aneurysm wall is associated with rupture: Histological analysis of 24 unruptured and 42 ruptured cases. Stroke; a journal of cerebral circulation. 2004;35:2287–2293. doi: 10.1161/01.STR.0000140636.30204.da. [DOI] [PubMed] [Google Scholar]
- 45.Kanematsu Y, Kanematsu M, Kurihara C, Tada Y, Tsou TL, van Rooijen N, Lawton MT, Young WL, Liang EI, Nuki Y, Hashimoto T. Critical roles of macrophages in the formation of intracranial aneurysm. Stroke; a journal of cerebral circulation. 2011;42:173–178. doi: 10.1161/STROKEAHA.110.590976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Korshunov VA, Berk BC. Strain-dependent vascular remodeling: The “glagov phenomenon” is genetically determined. Circulation. 2004;110:220–226. doi: 10.1161/01.CIR.0000134958.88379.2E. [DOI] [PubMed] [Google Scholar]
- 47.Korshunov VA, Berk BC. Flow-induced vascular remodeling in the mouse: A model for carotid intima-media thickening. Arteriosclerosis, thrombosis, and vascular biology. 2003;23:2185–2191. doi: 10.1161/01.ATV.0000103120.06092.14. [DOI] [PubMed] [Google Scholar]
- 48.Chiang HY, Korshunov VA, Serour A, Shi F, Sottile J. Fibronectin is an important regulator of flow-induced vascular remodeling. Arteriosclerosis, thrombosis, and vascular biology. 2009;29:1074–1079. doi: 10.1161/ATVBAHA.108.181081. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Jin SX, Shen LH, Nie P, Yuan W, Hu LH, Li DD, Chen XJ, Zhang XK, He B. Endogenous renovascular hypertension combined with low shear stress induces plaque rupture in apolipoprotein e-deficient mice. Arteriosclerosis, thrombosis, and vascular biology. 2012;32:2372–2379. doi: 10.1161/ATVBAHA.111.236158. [DOI] [PubMed] [Google Scholar]
- 50.Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, Wrenn SP, Narula J. Atherosclerotic plaque progression and vulnerability to rupture: Angiogenesis as a source of intraplaque hemorrhage. Arteriosclerosis, thrombosis, and vascular biology. 2005;25:2054–2061. doi: 10.1161/01.ATV.0000178991.71605.18. [DOI] [PubMed] [Google Scholar]
- 51.Kalsotra A, Cooper TA. Functional consequences of developmentally regulated alternative splicing. Nature reviews Genetics. 2011;12:715–729. doi: 10.1038/nrg3052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Merkin J, Russell C, Chen P, Burge CB. Evolutionary dynamics of gene and isoform regulation in mammalian tissues. Science. 2012;338:1593–1599. doi: 10.1126/science.1228186. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.





